| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_f04efe9857a8ec7c3bec13dd56c7c594 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2333-705
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2333-912 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q1-6881
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12P1-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N15-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Y207-10001
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q1-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-56966
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N5-0663
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-28 |
| classificationIPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12P21-08 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K16-28
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12P1-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N5-0775 |
| filingDate |
2015-07-31-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d56b4a2bca522999fb7255ac0af88796
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f3e8f8a91f8fd374a8e3648bab89fe9a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9e5c7706e84875e512a082d67041b020 |
| publicationDate |
2016-02-04-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
WO-2016017795-A1 |
| titleOfInvention |
Method for evaluating quality of human mesenchymal stem cell, and monoclonal antibody for use in said method |
| abstract |
The purpose of the present invention is to provide: a method for evaluating the quality of a human mesenchymal stem cell; a method for separating, selecting and culturing a human mesenchymal stem cell; a human mesenchymal stem cell population which can proliferate rapidly; and a monoclonal antibody which can specifically recognize a human mesenchymal stem cell that proliferates rapidly. Human mesenchymal stem cells that proliferate rapidly are separated and selected from a cell population containing human mesenchymal stem cells, and are then cultured. The abundance ratio of cells each having Ror2 or Fzd5 expressed therein in the cell population that has been separated, selected and cultured is quantified to determine whether or not the cell population passes or fails. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2021144995-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2021145002-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-20220003564-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2022163872-A1 |
| priorityDate |
2014-08-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |